News

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

  • Ms. Pratt, a seasoned mental health counselor with extensive academic and practical experience, will enhance the Company's Complete Care and Therapy services SALT LAKE CITY, UT / ACCESSWIRE / August 22, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce the appointment of Nancy Pratt, a clinical mental health counselor (CMHC), as Behavioral Health Program Director. Ms. Pratt will bolster the KindlyMD leadership team, driving the Company's Complete Care and Therapy services as a key part of their strategic mission to offer comprehensive, Complete Care programs for patients.
    08/22/2024

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

  • Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid, and Blue Cross Blue Shield Reimbursement from insurance payors increased 163.7% sequentially and is expected to increase as a percentage of total revenue going forward Reimbursements from insurance payors totaled $126,325 in first half of 2024 as compared to $0 during the first half of 2023 SALT LAKE CITY, UT / ACCESSWIRE / August 14, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the second quarter ended June 30, 2024 and is providing a shareholder update. Tim Pickett, PA-C, KindlyMD Founder and CEO, stated, "During the second quarter we successfully closed on our IPO for gross proceeds of approximately $6 million.
    08/14/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Kindly MD, Inc. Common Stock (KDLY) can sell. Click on Rating Page for detail.

The price of Kindly MD, Inc. Common Stock (KDLY) is 1.2 and it was updated on 2024-08-31 07:33:56.

Currently Kindly MD, Inc. Common Stock (KDLY) is in undervalued.

News
    
News

KindlyMD to Present at Upcoming August 2024 Investor Conferences

  • SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that management is scheduled to participate in the following August 2024 conferences. Sidoti Micro-Cap Virtual Conference Presentation Date and Time: Wednesday, August 14th at 11:30 a.m.
    Tue, Aug. 13, 2024

KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling

  • SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, announced today that it has submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA"), consistent with the view of the Department of Health and Human Services ("HHS") that cannabis has a currently accepted medical use as well as HHS's views concerning cannabis abuse potential and the level of physical or psychological dependence. For the past 54 years, cannabis has been categorized as a Schedule I controlled substance under the Controlled Substances Act.
    Thu, Jul. 25, 2024

3 Cannabis Stocks to Buy at a 52-Week Low in July

  • With the federal government moving to reschedule cannabis to Schedule III, effectively paving the way for medical cannabis legalization, cannabis stocks are in the spotlight. Cannabis stocks initially spiked on the news but quickly returned to previous levels.
    Wed, Jul. 17, 2024

3 IPO Gems Flying Under the Radar (for Now)

  • Though Reddit (NYSE: RDDT ) may have been the most recent big-name IPO, the initial listings market is still cooking, and undervalued IPO stocks abound. The last undervalued IPO stock I picked at the beginning of June, Nano Nuclear Energy (NASDAQ: NNE ), returned over 300% since I first noticed it, further proving that undervalued IPO stocks are out there if you know where to look.
    Wed, Jul. 03, 2024

KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah's Top Insurance Payors

  • KindlyMD is now providing nearly 80% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / June 17, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received additional credentialing and is now proudly contracted with Blue Cross Blue Shield under Utah's top insurance payors. The Company recently announced it became one of the first alternative medical treatment companies in the state to receive this status, with the contracts of Select Health, Medicare, and Medicaid.
    Mon, Jun. 17, 2024
More Headlines
News

KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah

  • Community care events to be held throughout summer at Curaleaf's Lehi, Provo, and Payson, Utah Medical Cannabis Pharmacies SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2024 / KindlyMD, Inc. ("KindlyMD" or "the Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced a strategic collaboration with Curaleaf Holdings, Inc. (TSX:CURA)(OTCQX:CURLF) ("Curaleaf"), a leading international provider of consumer products in cannabis. Under the terms of the collaboration, KindlyMD and Curaleaf will work together to provide educational resources and information with a community perspective on holistic pain management and treatment.
  • 06/10/2024

KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors

  • Insurance payors include Medicare, Utah's largest insurer, Select Health, and Medicaid, providing KindlyMD nearly 70% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / June 5, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received credentialing and is contracted under Utah's top insurance payors, becoming the first alternative medical treatment company in the state to receive this status. Kindly MD, Inc. is currently contracted with Select Health, Medicare, and Medicaid.
  • 06/05/2024

KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th

  • SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced that Tim Pickett, Founder and Chief Executive Officer, is scheduled to present at the KCSA Cannabis Virtual Conference on Wednesday, June 5th at 3 p.m. ET. Registration Link: https://bit.ly/3QVIu08 If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available.
  • 06/04/2024

WallachBeth Announces Closing of KindlyMD's $6.8m IPO

  • JERSEY CITY, N.J. , June 3, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that KindlyMD, Inc. (NASDAQ: KDLY; KDLYW) a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies has completed its previously announced IPO of 1,240,910 units at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company, prior to deducting underwriting discounts and offering expenses.
  • 06/03/2024

KindlyMD Announces Closing of $6.8 Million Initial Public Offering

  • SALT LAKE CITY, UT / ACCESSWIRE / June 3, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the closing of its previously announced initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company, prior to deducting underwriting discounts and offering expenses. Each Unit is comprised of one share of the Company's common stock with $0.001 par value per share ("Common Stock"), one tradeable warrant (each, a "Tradeable Warrant," collectively, the "Tradeable Warrants") to purchase one share of Common Stock at an exercise price of $6.33 per share, and one non-tradeable warrant (each, a "Non-tradeable Warrant," collectively, the "Non-tradeable Warrants") to purchase one-half of one share of Common Stock at an exercise price of $6.33 per share.
  • 06/03/2024

WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO

  • JERSEY CITY, N.J. , May 31, 2024 /PRNewswire/ -- KindlyMD, Inc. (NASDAQ: KDLY; KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the pricing of its initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company.
  • 05/31/2024

KindlyMD Announces Pricing of $6.8 Million Initial Public Offering

  • SALT LAKE CITY, UT / ACCESSWIRE / May 31, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the pricing of its initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company. Each Unit is comprised of one share of the Company's common stock with $0.001 par value per share ("Common Stock"), one tradeable warrant (each, a "Tradeable Warrant," collectively, the "Tradeable Warrants") to purchase one share of Common Stock at an exercise price of $6.33 per share, and one non-tradeable warrant (each, a "Non-tradeable Warrant," collectively, the "Non-tradeable Warrants") to purchase one-half of one share of Common Stock at an exercise price of $6.33 per share.
  • 05/31/2024
Unlock
KDLY Ratings Summary
KDLY Quant Ranking